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1  | INTRODUC TION
Complete trisomy 22, the second most common chromosomal an-
euploidy, occurs in about 2.9% of spontaneous abortions.1 It is ex-
tremely incompatible with life and the average survival of affected 
children is 4 days.2 The incidence of trisomies 22 (both mosaic 
and non- mosaic forms) among miscarriage cases is 9- 20 cases per 
100 000.3 Mosaic trisomy 22 is a rare anomaly which has prolonged 
survival compatibility; therefore, recognition of full trisomy 22 from 
the mosaic form is critical for genetic counseling. Affected mosaic 
cases have prevalent clinical presentations, such as webbed neck, 
developmental delay, abnormal ears, cardiac disorders including 
congenital heart diseases (CHDs), and microcephaly.4 The diagnosis 
of a mosaic trisomy 22 is usually complicated for the present/absent 
of mosaicism in tissue or hematological cell lines; that is, not all pa-
tients of mosaic trisomy 22 are detectable in cultured blood cells, 
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Background: Trisomy 22 mosaicism is a rare autosomal anomaly with survival com-
patibility. Recognition of the complete trisomy 22 which is incompatible with life 
from the mosaic form is critical for genetic counseling. Affected mosaic cases have 
prevalent clinical presentations such as webbed neck, developmental delay, abnor-
mal ears, cardiac disorders, and microcephaly. Phenotype of these patients is milder 
than full chromosomal aneuploidy, and the severity of the phenotype depends on the 
count of trisomic cells. We describe a 4- year- old boy with mosaic trisomy 22 from 
healthy parents and no family history of any genetic disorders in the pedigree.
Method and Results: The patient had determined dysmorphic clinical features in-
cluding facial asymmetry, cleft palate, gastroenteritis, hydronephrosis, developmen-
tal delay, genital anomalies, dysplastic toenails, flattened nasal bridge, congenital 
heart defect, hearing loss, cryptorchidism, and hypotonic muscle. He is the first re-
ported with hypothyroidism and larynx wall thickness in worldwide and the first with 
atrial septal defect (ASD) from Iran. Chromosomal analyses using G- banding indi-
cated a de novo Mos 47,XY,+22(6)/46,XY(44) karyotype with no other chromosomal 
structural changes.
Conclusions: Our observations confirm the importance of cytogenetic analyses for 
determining the cause of congenital anomalies and provide a useful genetic coun-
seling. In addition, due to the fact that some of mosaic trisomy 22 features are una-
voidable such as CHD and general hypotrophy, we suggest including echocardiography 
test for early diagnosis during the clinical assessment.
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the difference between various tissues in the mosaicism level, and 
the paternal/maternal uniparental disomy. Furthermore, establishing 
a trusty relevance between the mosaic trisomy 22 phenotype and 
karyotype is difficult.5
Congenital heart diseases are the common cause of pediatric 
mortalities which occur in 8 per 1000 live births. Atrial septal defect 
(ASD) often occurs in 7%- 11% of CHD cases.6 Overall, about 33%- 
42% of CHD are associated with chromosomal aneuploidy and the 
majority of the individuals with CHD having an aneuploidy harbors 
extracardiac deformities.7 In published studies, documented mosaic 
trisomy 22 has been identified in patients with some of CHD types 
such as ventricular septal defect (VSD), pulmonary stenosis (PS), 
aortic stenosis (AS), and ASD.1 Nevertheless, the spectrum of CHD 
related to mosaic trisomy 22 has not been well described.
Herein, we present a patient with ASD in addition to other previ-
ously reported symptoms of the mosaic trisomy 22.8 To our knowl-
edge, this is the first report of a mosaic trisomy 22 with ASD from 
Iran. Our finding indicates that patients with asymmetry and CHD 
should be surveyed for mosaic trisomy 22.
2  | MATERIAL S AND METHODS
2.1 | Case clinical studies
This 4- year- old Iranian boy was the second and last child of the 
studied family. His younger brother was healthy and 12 years 
old. The parents were healthy and third- degree consanguine-
ous. Father’s age was 39 years and mother was 35 years old. In 
the last days of the pregnancy with the affected son, the mother 
had abnormal excessive weight gain. There was no family history 
of any genetic disorders in pedigree. Due to heart- stopping of the 
newborn during the spontaneous vaginal delivery, the patient was 
born by emergency cesarean section. The length, weight, and head 
circumference of the birth were 51 cm, 2400 g, and 32 cm, respec-
tively. He was hospitalized at the age of 45 days because of failure 
in gaining sufficient weight and feeding problems, at that time, he 
was recognized by an echocardiogram to have ASD (Figure 1). The 
seizure co- occurred with heart- stopping once in the second month 
of the life but he had normal brain MRI (magnetic resonance imag-
ing) and normal intelligence. At age 1 year, he underwent surgery 
for his large ASD.
The clinical findings were as below (Figure 2): the facial asym-
metry was noticeable, the right- side ear was small and rotated; 
that is, hypoplasia of the antitragus, tragus, and lower helix, and 
audiological evaluations indicated both of ears had hearing loss. 
His right eye and eyelid were normal, but the left eye had esotropia 
and blepharoptosis. His growth was extremely slowly; at 3 years, 
length and weight were 78 cm and 8000 g, a late gain head control 
(at 8 months), lack of creep, talk, and walk. He suffered from cleft 
palate up to the age of 1 year, hypothyroidism, hydronephrosis, 
gastroenteritis, and dental anomaly. He had flattened nasal bridge, 
low hairline, no feet nails up to the age of 3½ years, flat hands 
nails, that is, dysplastic toenails, hypotonic muscle, and robust cry-
ing which were detected by laryngoscopy to have thickening in the 
larynx wall. He harbored hypospadias, unilateral cryptorchidism, 
and ambiguous genitalia, that is, at 2 months of age; moreover, ge-
netic and endocrine examinations determined the baby sexual as 
male. In addition, on repeated hematology and biochemistry tests, 
the patient values were nearly in normal ranges as indicated in 
Table 1.9,10
2.2 | Cytogenetic analyses
With informed consent of the case parents, the karyotype (GTG- 
banding) of peripheral blood lymphocytes from the affected son 
and his parents was performed. Lymphocyte cells were cultured 
in medium with RPMI 1640, penicillin, fetal bovine serum (FBS), 
L- glutamin 200 mmol/L, and phytohemaglutinin (PHA). After 
72 hours culture at 37°C, Colcemide was added to cultured tube 
and harvested base on the standard protocols.11 Metaphase 
spreads were stained by Giemsa (G- banding), and 50 cells were 
analyzed at a resolution of 450- 550 bands according to the lab 
protocol. The karyotype was described based on the International 
System for Human Cytogenetic Nomenclature (ISCN 2016).12 
This study was performed due to the Declaration of Helsinki 
Principles and was reviewed by the ethics committee of Rajaie 
Cardiovascular, Medical and Research Center.
F IGURE  1 Cardiac defect analyses: the echocardiograph image 
indicating the atrial septal defect
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F IGURE  2 The patient at 4 years of 
age. A, Ear asymmetry and the flattened 
nasal bridge. B, Dental anomaly. C, Left  
eye: esotropia and blepharoptosis. 
D, Dysplastic toenails. E, Ambiguous 







TABLE  1 Hematological and biochemical analyses of the patient
Parameters (unit)
Measured values in the 
patient Reference values
Hematology White blood cell count (x103) 10.2 6.3- 16.3
Red blood cell count (x106) 4.6 (L)d 4.7- 5.7
Hemoglobin (g/dL) 12.5 (L)d 13.7- 18.1
Hematocrit (%) 37.5 (L)d 41.0- 54.0
Neutropenia (segs)x103 6.9 2.0- 10.2
Lymphocytes (x103) 5.8 3.1- 7.9
Platelet (x103) 156 (L)d 202- 557
MCV (fL)a 81.2 80.8- 100.9
MCH (pg)b 27.5 27.3- 34.1
MCHC (g/dL)c 33.9 32.0- 36.0
Biochemistry Sodium (mmol/L) 138 133- 146
Potassium (mmol/L) 4.7 3.5- 6.5
Glucose (mg/dL) 100 70- 115
Creatinine (mg/dL) 0.2 (L)d 0.6- 1.4







Troponin (μg/L) 6.44 (H)* <0.16
Alkaline phosphatase (U/L) 169 <269
Blood urea nitrogen (mg/dL) 14 7- 20
C- reactive protein (mg/L) 2.5 0.3- 5
Total bilirubin (μmol/L) 6 2- 14
aMCV, mean cell volume; fL = (Hct [in L/L]/RBC [in x1012/L]) x 1000. 
bMCH, mean cell hemoglobin. 
cMCHC, mean corpuscular hemoglobin concentration.*L, low; H, high.  
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3  | RESULT
Chromosomal assessment of peripheral blood cells (50 metaphases) 
from patient indicated a male karyotype which contained six clones 
with trisomy 22 and forty- four clones with a usual male karyotype. 
The mosaic trisomy 22 karyotype was determined as Mos 47,XY,+22 
(6)/46,XY(44), as shown in Figure 3. No other chromosomal struc-
tural changes were found in the karyotype. Also, the parent’s normal 
chromosomes were determined as 46, XY and 46, XX for the father 
and the mother, respectively.
4  | DISCUSSION
A 4- year- old boy presented in our study, harbored a de novo mo-
saic trisomy 22. Apparently, the existence of the additional chromo-
some 22 in some of the patient’s metaphase spreads is the cause of 
clinical findings that determine the disease.13 Our patient displayed 
the most of the known symptoms of this mosaicism including ear 
problem (facial and hearing), developmental delay, genital anomalies, 
dysplastic toenails, flattened nasal bridge, congenital heart defect, 
cryptorchidism, and hypotonic muscle.
This patient had large ASD without any other types of CHD, 
although the most published reports indicated complex CHD; our 
finding was somewhat similar to Abdelgadir et al14 publication, that 
they determined ASD and tetralogy of Fallot (TOF) in their patients 
and Abdelmoula et al13 study, which a patient with ASD, patent 
ductus arteriosus (PDA) and PS was reported. Our case had hypo-
thyroidism, although he was thin and weak, to our knowledge, this 
clinical feature has not been previously described in mosaic trisomy 
22 cases. In addition, we found no study reporting larynx wall thick-
ness in trisomy 22 mosaicism observed in our patient. High mater-
nal age is related to a risk of aneuploidy, and it should be concluded 
whether this subject is or is not related with trisomy 22 because the 
age of our patient mother was 31 and the average age of women 
pregnancy had increased over the past years. Although it appears 
that the patients with mosaic trisomy 22 are females more than 
males, whereas our patient karyotype and endocrine evaluation in-
dicated male. The microcephaly and intellectual disability are often 
reported in mosaic patients with trisomy 2215-18; however, they were 
not observed in our case, and our patient had normal intelligent as 
assessed by the Raven test, similar to Lacassie et al3 report which 
described a 5- year- old girl with normal intelligent. Phenotype in 
patients with mosaic chromosomal abnormality is milder than full 
chromosomal aneuploidy. In addition, mosaic trisomy 22 has vari-
ous clinical features which the severity of these symptoms is varied 
depending on the count of extra chromosome 22 cells. The patients 
with low trisomy 22 spreads have fewer symptoms of the mosaic 
trisomy 22.13 Therefore, it is possible that healthy mental pheno-
type in our case is related to the low level of the mosaicism (12%). 
Mosaicism occurs because of errors in the fetal mitosis division or 
is the result of father/mother uniparental disomy which the second 
F IGURE  3 The karyotype indicating mosaic 47,XY,+22(6)/46,XY(44)
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cause is a rare reason. However, it has been reported by Pater et al19 
that the maternal uniparental disomy has not any effect on patient 
features unless it happens in mosaic condition with a trisomy 22; 
in that time, the patient indicates some of the Turner syndrome 
characterizes. It is impossible to recognize the parental origin of the 
additional 22 in the patient without extragenetic investigation. The 
low- level mosaicism observed in our patient blood cells, with normal 
chromosome of the parents, resulting in concluding the postmei-
otic nondisjunctional error occurred. When symptoms are present 
in the patient but the peripheral blood cells lacked mosaic trisomy 
22, the evaluation of the tissue is necessary and important. In study 
of Abdelgadir et al14 30% of patients had blood lymphocytes mo-
saic karyotype while about 90% harbored skin mosaic karyotype. 
Furthermore, there are some publications reporting that mosaicism 
determined by blood cells is lower than tissue cells, that is, skin par-
ticularly.18,20,21 In cases with low level of mosaicism, the FISH and 
molecular studies should be performed for confirmation.22 As a lim-
itation of our study, we were unable to survey any more mainly due 
to migration of this family to another remote place, but the present 
of more symptoms of the mosaic trisomy 22 in this patient can be a 
validation for our diagnosis.
In conclusion, chromosomal aneuploidy should be investigated in 
any child with multiple anomalies. Moreover, we think further tissue 
chromosomal evaluation in defined cases with normal blood karyo-
type is necessary. Regarding that some of mosaic trisomy 22 features 
are unavoidable such as CHD and general hypotrophy, we suggest 
including echocardiography test for early diagnosis during the clin-
ical assessment. Moreover, these mosaic trisomy 22 indicative fea-
tures may guide clinician to distinguish chromosomal mosaicism.
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